Arvinas (ARVN) EPS (Basic) (QoQ) (2017 - 2026)
Powered by 
Analysis
Arvinas (ARVN) EPS (Basic) (QoQ) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | Arvinas | 607.18 Mn | 39.28 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 390.47% |
| Mar 31, 2026 | 5.33% |
| Dec 31, 2025 | -98.25% |
| Sep 30, 2025 | 42.80% |
| Jun 30, 2025 | -173.32% |
| Mar 31, 2025 | 282.29% |
| Dec 31, 2024 | 8.08% |
| Sep 30, 2024 | -39.39% |
| Jun 30, 2024 | 49.42% |
| Mar 31, 2024 | 65.30% |
| Dec 31, 2023 | -136.14% |
| Sep 30, 2023 | 3.41% |
| Jun 30, 2023 | 19.33% |
| Mar 31, 2023 | -0.68% |
| Dec 31, 2022 | -26.54% |
| Sep 30, 2022 | 6.22% |
| Jun 30, 2022 | -10.06% |
| Mar 31, 2022 | -25.04% |
| Dec 31, 2021 | 1.87% |
| Sep 30, 2021 | 8.73% |